Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-21-039056

Options or other derivatives

  • Director sold 81,872 shares at an average $0.27 ($22,132)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
NEIS JOHN Director 2021-03-17 Sale · Series A Warrants −58,640 $0.28 $16,273 23,232 D
NEIS JOHN Director 2021-03-18 Sale · Series A Warrants −23,232 $0.25 $5,859 0 D
Loading xslF345X03/tm2110277d1_4seq1.xml…